文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

GLP-1:一个复杂信号系统的分子机制和结果。

GLP-1: Molecular mechanisms and outcomes of a complex signaling system.

机构信息

Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, TN, USA.

Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Neurochem Int. 2019 Sep;128:94-105. doi: 10.1016/j.neuint.2019.04.010. Epub 2019 Apr 17.


DOI:10.1016/j.neuint.2019.04.010
PMID:31002893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7081944/
Abstract

Meal ingestion provokes the release of hormones and transmitters, which in turn regulate energy homeostasis and feeding behavior. One such hormone, glucagon-like peptide-1 (GLP-1), has received significant attention in the treatment of obesity and diabetes due to its potent incretin effect. In addition to the peripheral actions of GLP-1, this hormone is able to alter behavior through the modulation of multiple neural circuits. Recent work that focused on elucidating the mechanisms and outcomes of GLP-1 neuromodulation led to the discovery of an impressive array of GLP-1 actions. Here, we summarize the many levels at which the GLP-1 signal adapts to different systems, with the goal being to provide a background against which to guide future research.

摘要

进食会引发激素和神经递质的释放,而这些物质反过来又调节能量平衡和进食行为。胰高血糖素样肽-1(GLP-1)就是这样一种激素,由于其强大的肠促胰岛素作用,它在肥胖和糖尿病的治疗中受到了广泛关注。除了 GLP-1 的外周作用外,这种激素还能够通过调节多个神经回路来改变行为。最近的研究工作集中在阐明 GLP-1 神经调节的机制和结果,这导致了对 GLP-1 作用的一系列令人印象深刻的发现。在这里,我们总结了 GLP-1 信号适应不同系统的多个层面,目的是提供一个背景,以指导未来的研究。

相似文献

[1]
GLP-1: Molecular mechanisms and outcomes of a complex signaling system.

Neurochem Int. 2019-4-17

[2]
Therapies for inter-relating diabetes and obesity - GLP-1 and obesity.

Expert Opin Pharmacother. 2014-9-26

[3]
Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behavior.

Physiol Behav. 2014-9

[4]
Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.

Diabetes Obes Metab. 2016-6-7

[5]
Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus.

Basic Res Cardiol. 2013-6-14

[6]
Glucagon-Like Peptide-1 (GLP-1) in the Integration of Neural and Endocrine Responses to Stress.

Nutrients. 2020-10-28

[7]
The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors.

Am J Physiol Endocrinol Metab. 2013-10-8

[8]
GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans.

Diabetes. 2014-7-28

[9]
Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.

Diabetologia. 2011-7-9

[10]
The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications.

Diabetes Obes Metab. 2014-1

引用本文的文献

[1]
The multifaceted effects of semaglutide: exploring its broad therapeutic applications.

Future Sci OA. 2025-12

[2]
Semaglutide and human reproduction: caution at the intersection of energy balance, ovarian function, and follicular development.

Reprod Biol Endocrinol. 2025-8-8

[3]
Incretin-Based Therapies in Alzheimer's and Parkinson's Disease: Advancing Neuroprotection With Dual and Triple Agonists-A Review.

Health Sci Rep. 2025-7-15

[4]
Heat-Inactivated pA1cHI Maintains Glycemic Control and Prevents Body Weight Gain in High-Fat-Diet-Fed Mice.

Int J Mol Sci. 2025-7-3

[5]
Structure-Based Discovery of Orthosteric Non-Peptide GLP-1R Agonists via Integrated Virtual Screening and Molecular Dynamics.

Int J Mol Sci. 2025-6-26

[6]
A Novel GLP-1 and FGF21 Fusion Protein for the Treatment of Non-alcoholic Steatohepatitis (NASH).

Adv Pharm Bull. 2024-12-10

[7]
Six-year follow-up of an abstinence-based, food addiction recovery approach to weight management.

Front Psychiatry. 2025-6-2

[8]
Kisspeptin Receptor Agonists and Antagonists: Strategies for Discovery and Implications for Human Health and Disease.

Int J Mol Sci. 2025-5-20

[9]
The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort.

Biomedicines. 2025-4-26

[10]
Current and Emerging Parenteral and Peroral Medications for Weight Loss: A Narrative Review.

Diseases. 2025-4-22

本文引用的文献

[1]
Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease.

Nature. 2019-1-30

[2]
Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function.

Front Endocrinol (Lausanne). 2018-11-23

[3]
Defined Paraventricular Hypothalamic Populations Exhibit Differential Responses to Food Contingent on Caloric State.

Cell Metab. 2018-11-21

[4]
Role of Bile Acids and GLP-1 in Mediating the Metabolic Improvements of Bariatric Surgery.

Gastroenterology. 2018-11-13

[5]
Differential engagement of polar networks in the glucagon-like peptide 1 receptor by endogenous variants of the glucagon-like peptide 1.

Biochem Pharmacol. 2018-8-25

[6]
Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells.

Mol Metab. 2018-7-30

[7]
Anti-Obesity Therapy: from Rainbow Pills to Polyagonists.

Pharmacol Rev. 2018-10

[8]
GLP-1 neurons form a local synaptic circuit within the rodent nucleus of the solitary tract.

J Comp Neurol. 2018-9-19

[9]
A Neural Circuit for the Suppression of Pain by a Competing Need State.

Cell. 2018-3-22

[10]
Endogenous GLP-1 in lateral septum contributes to stress-induced hypophagia.

Physiol Behav. 2018-8-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索